Apidra SoloSTAR insulin pen approved

The FDA has approved Apidra SoloSTAR (insulin glulisine [rDNA origin] injection, from sanofi-aventis), a prefilled disposable pen containing Apidra.  Apidra SoloSTAR makes administration of insulin more convenient for patients with insulin regimens that require rapid-acting Apidra.  It is expected to be available in pharmacies this year.

Apidra is indicated to improve glycemic control in adults and children ≥4 years of age with type 1 diabetes or adults with type 2 diabetes.

For more information call (800) 633-1610 or visit www.Apidra.com.